Report
EUR 10.00
For Business Accounts Only
Medtronic Plc. (NYSE: MDT) to Separate its Diabetes Business
On May 21, 2025, Medtronic plc (NYSE: MDT) announced plans to separate its Diabetes business into a separate, publicly traded company. The separation will occur via a two step transaction - an initial minority IPO carve-out followed by a split-off of the remaining stake. The separation will be tax-free for the shareholders and is expected to be completed in the next 18 months.
Underlying
MEDTRONIC PLC
Provider
GSBR Research Pvt Ltd
GSBR Research is an independent equity research provider focused on covering global markets. We cover companies across sectors with special focus on small and mid cap. We also track special situations specifically spin-offs/demergers.
Garvit Bhandari
Other Reports on these Companies
Other Reports from GSBR Research Pvt Ltd
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.